NicVAX/Placebo as an Aid for Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Smoking CessationSmokingTobacco Cessation
Interventions
BIOLOGICAL

NicVAX vaccine

NicVAX vaccine given 6 times over 6 months

BIOLOGICAL

Placebo vaccine

Placebo vaccine given 6 times over 6 months

Trial Locations (22)

Unknown

NicVAX Investigator, Tucson

NicVAX Investigator, Los Angeles

NicVAX Investigator, Newport Beach

NicVAX Investigator, San Diego

NicVAX Investigator, Denver

NicVAX Investigator, Farmington

NicVAX Investigator, Miami

NicVAX Investigator, St. Petersburg

NicVAX Investigator, Boise

NicVAX Investigator, Lexington

NicVAX Investigator, Baltimore

NicVAX Investigator, College Park

NicVAX Investigator, Boston

NicVAX Investigator, Minneapolis

NicVAX Investigator, Omaha

NicVAX Investigator, Rochester

NicVAX Investigator, Raleigh

NicVAX Investigator, Portland

NicVAX Investigator, Draper

NicVAX Investigator, Norfolk

NicVAX Investigator, Seattle

NicVAX Investigator, Madison

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Nabi Biopharmaceuticals

INDUSTRY

NCT00836199 - NicVAX/Placebo as an Aid for Smoking Cessation | Biotech Hunter | Biotech Hunter